This article was originally published in The Gray Sheet
Launches the GEM DR model 7271 full-featured, dual chamber, rate responsive pacemaker/defibrillator system in Europe. The device incorporates Active Can technology as well as Medtronic's PR Logic dual chamber detection algorithm to discriminate between fast ventricular rhythms that are life-threatening and fast atrial arrhythmias that are not. At 62 cc, the 35 joule GEM DR is the world's smallest defibrillator and is anticipated to last seven to nine years under typical use conditions. A May 8 premarket approval application submission is pending at FDA for the device
You may also be interested in...
Sanofi’s sales grew strongly in the second quarter, driven by the immunologic Dupixent and its vaccines business, with the company also reporting success in a further potential indication for the product, chronic spontaneous urticaria. The big pharma has raised its EPS guidance for the year.
The UK company has raised its forecasts for 2021 after a better-than-expected Q2, even though Vaxzevria remains a very mixed blessing.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.